Correlation Between Atea Pharmaceuticals and Recursion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Atea Pharmaceuticals and Recursion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atea Pharmaceuticals and Recursion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atea Pharmaceuticals and Recursion Pharmaceuticals, you can compare the effects of market volatilities on Atea Pharmaceuticals and Recursion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atea Pharmaceuticals with a short position of Recursion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atea Pharmaceuticals and Recursion Pharmaceuticals.
Diversification Opportunities for Atea Pharmaceuticals and Recursion Pharmaceuticals
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Atea and Recursion is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Atea Pharmaceuticals and Recursion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Recursion Pharmaceuticals and Atea Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atea Pharmaceuticals are associated (or correlated) with Recursion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Recursion Pharmaceuticals has no effect on the direction of Atea Pharmaceuticals i.e., Atea Pharmaceuticals and Recursion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Atea Pharmaceuticals and Recursion Pharmaceuticals
Given the investment horizon of 90 days Atea Pharmaceuticals is expected to under-perform the Recursion Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Atea Pharmaceuticals is 2.01 times less risky than Recursion Pharmaceuticals. The stock trades about -0.26 of its potential returns per unit of risk. The Recursion Pharmaceuticals is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 721.00 in Recursion Pharmaceuticals on November 3, 2024 and sell it today you would earn a total of 3.00 from holding Recursion Pharmaceuticals or generate 0.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Atea Pharmaceuticals vs. Recursion Pharmaceuticals
Performance |
| Timeline |
| Atea Pharmaceuticals |
| Recursion Pharmaceuticals |
Atea Pharmaceuticals and Recursion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Atea Pharmaceuticals and Recursion Pharmaceuticals
The main advantage of trading using opposite Atea Pharmaceuticals and Recursion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atea Pharmaceuticals position performs unexpectedly, Recursion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Recursion Pharmaceuticals will offset losses from the drop in Recursion Pharmaceuticals' long position.| Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |